Literature DB >> 26379089

RNAP II processivity is a limiting step for HIV-1 transcription independent of orientation to and activity of endogenous neighboring promoters.

Katarzyna Kaczmarek Michaels1, Frank Wolschendorf2, Gillian M Schiralli Lester3, Malini Natarajan4, Olaf Kutsch2, Andrew J Henderson5.   

Abstract

Since HIV-1 has a propensity to integrate into actively expressed genes, transcriptional interference from neighboring host promoters has been proposed to contribute to the establishment and maintenance HIV-1 latency. To gain insights into how endogenous promoters influence HIV-1 transcription we utilized a set of inducible T cell lines and characterized whether there were correlations between expression of endogenous genes, provirus and long terminal repeat architecture. We show that neighboring promoters are active but have minimal impact on HIV-1 transcription, in particular, expression of the endogenous gene did not prevent expression of HIV-1 following induction of latent provirus. We also demonstrate that releasing paused RNAP II by diminishing negative elongation factor (NELF) is sufficient to reactivate transcriptionally repressed HIV-1 provirus regardless of the integration site and orientation of the provirus suggesting that NELF-mediated RNAP II pausing is a common mechanism of maintaining HIV-1 latency.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV latency; NELF; RNA Polymerase II pausing; Transcription interference

Mesh:

Substances:

Year:  2015        PMID: 26379089      PMCID: PMC4679410          DOI: 10.1016/j.virol.2015.08.027

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  39 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Negative elongation factor (NELF) coordinates RNA polymerase II pausing, premature termination, and chromatin remodeling to regulate HIV transcription.

Authors:  Malini Natarajan; Gillian M Schiralli Lester; Chanhyo Lee; Anamika Missra; Gregory A Wasserman; Martin Steffen; David S Gilmour; Andrew J Henderson
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

3.  Transcriptional interference perturbs the binding of Sp1 to the HIV-1 promoter.

Authors:  I H Greger; F Demarchi; M Giacca; N J Proudfoot
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

4.  The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation.

Authors:  C Van Lint; S Emiliani; E Verdin
Journal:  Gene Expr       Date:  1996

5.  Nuclear architecture dictates HIV-1 integration site selection.

Authors:  Bruna Marini; Attila Kertesz-Farkas; Hashim Ali; Bojana Lucic; Kamil Lisek; Lara Manganaro; Sandor Pongor; Roberto Luzzati; Alessandra Recchia; Fulvio Mavilio; Mauro Giacca; Marina Lusic
Journal:  Nature       Date:  2015-03-02       Impact factor: 49.962

6.  Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription.

Authors:  M K Lewinski; D Bisgrove; P Shinn; H Chen; C Hoffmann; S Hannenhalli; E Verdin; C C Berry; J R Ecker; F D Bushman
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Determinants of the establishment of human immunodeficiency virus type 1 latency.

Authors:  Alexandra Duverger; Jennifer Jones; Jori May; Frederic Bibollet-Ruche; Frederic A Wagner; Randall Q Cron; Olaf Kutsch
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

8.  Identification of genes associated with tumorigenesis of meibomian cell carcinoma by microarray analysis.

Authors:  Arun Kumar; Syril Kumar Dorairaj; Venkatesh C Prabhakaran; D Ravi Prakash; Sanjukta Chakraborty
Journal:  Genomics       Date:  2007-09-21       Impact factor: 5.736

9.  Mechanisms of HIV Transcriptional Regulation and Their Contribution to Latency.

Authors:  Gillian M Schiralli Lester; Andrew J Henderson
Journal:  Mol Biol Int       Date:  2012-06-03

Review 10.  Human immunodeficiency virus (HIV)-1 integration sites in viral latency.

Authors:  Simin D Rezaei; Paul U Cameron
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

View more
  5 in total

Review 1.  Experimental Systems for Measuring HIV Latency and Reactivation.

Authors:  Koh Fujinaga; Daniele C Cary
Journal:  Viruses       Date:  2020-11-09       Impact factor: 5.048

2.  Extensive proteomic and transcriptomic changes quench the TCR/CD3 activation signal of latently HIV-1 infected T cells.

Authors:  Eric Carlin; Braxton Greer; Kelsey Lowman; Alexandra Duverger; Frederic Wagner; David Moylan; Alexander Dalecki; Shekwonya Samuel; Mildred Perez; Steffanie Sabbaj; Olaf Kutsch
Journal:  PLoS Pathog       Date:  2021-01-19       Impact factor: 6.823

3.  The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb.

Authors:  Panpan Lu; Xiying Qu; Yinzhong Shen; Zhengtao Jiang; Pengfei Wang; Hanxian Zeng; Haiyan Ji; Junxiao Deng; Xinyi Yang; Xian Li; Hongzhou Lu; Huanzhang Zhu
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.379

4.  The bromodomain and extraterminal domain inhibitor bromosporine synergistically reactivates latent HIV-1 in latently infected cells.

Authors:  Hanyu Pan; Panpan Lu; Yinzhong Shen; Yanan Wang; Zhengtao Jiang; Xinyi Yang; Yangcheng Zhong; He Yang; Inam Ulla Khan; Muya Zhou; Bokang Li; Ziyu Zhang; Jianqing Xu; Hongzhou Lu; Huanzhang Zhu
Journal:  Oncotarget       Date:  2017-10-06

5.  Bromodomain and Extra-Terminal Inhibitor BMS-986158 Reverses Latent HIV-1 Infection In Vitro and Ex Vivo by Increasing CDK9 Phosphorylation and Recruitment.

Authors:  Xu-Sheng Huang; Ren-Rong Tian; Meng-Di Ma; Rong-Hua Luo; Liu-Meng Yang; Guang-Hui Peng; Mi Zhang; Xing-Qi Dong; Yong-Tang Zheng
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.